Come up with a name for your new list and we'll add to it:
Speclipse was acquired by
Lindeman Asia Investment on November 05, 2019.
Speclipse develops technology for real-time, non-invasive, in-vivo cancer diagnosis utilizing laser spectroscopy and machining learning algorithms. The company's Spectra-Scope, available as either a s…